
FDA Approves Updated Pfizer-BioNTech and Moderna COVID Vaccines for 2026-27 Season
The U.S. Food and Drug Administration has approved updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, specifically formulated to target the XFG variant for the 2026-2027 season. The decision clears the way for domestic manufacturers to begin distributing the updated shots to healthcare providers.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (42/100)Sources
Pfizer, BioNTech win approval for updated COVID-19 shot
Read full article →US FDA approves updated COVID vaccines for 2026-27 season
By Reuters
Read full article →Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine - Taiwan News
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine Taiwan News
Read full article →

